Burdenko's Glioblastoma Progression Dataset (Burdenko-GBM-Progression)

The Burdenko Glioblastoma Progression Dataset (BGPD) is a systematic data collection from 180 patients with primary glioblastoma treated at the Burdenko National Medical Research Center of Neurosurgery between 2014 and 2020. 
For each patient, the dataset includes imaging studies conducted for radiotherapy planning and follow-up studies. The radiotherapy studies consist of 4 MRI sequences (T1, T1C, T2, FLAIR), a topometric CT scan, and associated radiotherapy planning files (RTSTRUCT, RTPlan, and RTDose). Follow-up studies (from 1 to 8-time per patient) include 2-4 MRI sequences (with a minimal set of T1C and FLAIR) per patient. Additional genetic information (IDH1/2, MGMT mutations); and a treatment response status (tumour progression, tumour pseudoprogression, treatment response) are available for a subset of patients.

布尔登科胶质母细胞瘤进展数据集（Burdenko Glioblastoma Progression Dataset, BGPD）是2014年至2020年间，于布尔登科国家神经外科医学研究中心接受治疗的180例原发性胶质母细胞瘤患者的系统性临床数据集。针对每位患者，该数据集包含用于放射治疗规划的影像学检查数据与随访影像学检查数据。其中，放射治疗规划相关影像学检查包含4种MRI序列（T1、T1C、T2、FLAIR）、1次定位CT扫描，以及配套的放射治疗计划文件（RTSTRUCT、RTPlan、RTDose）。每位患者的随访影像学检查次数为1至8次，每次检查包含2至4种MRI序列，且至少包含T1C与FLAIR序列。另有部分患者附带了遗传学信息（IDH1/2、MGMT基因突变）以及治疗应答状态（肿瘤进展、肿瘤假性进展、治疗应答）。